89. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freie Vorträge

Kardio-Onkologie

Vorsitz: Z. Kaya (Heidelberg), M. Totzeck (Essen)

	(V1644)	Thoracic radiation is associated with a subsequent reduction in ventricular arrhythmic events in cancer patients with implantable devices
		J. P. Münster, M. Heckmann, F. Schunn, C. Mages, C. Schmidt, P. Lugenbiel, J. Debus, N. Frey, L. H. Lehmann (Heidelberg)
		Diskussion
	(V1645)	SCORE2 predicts cardiovascular toxicity in patients undergoing ICI therapy - data from the ECoR registry
		S. Margraf, J. Pohl, L. Michel, L. Scheipers, T. Rassaf, M. Totzeck, R. Mincu (Essen)
		Diskussion
	(V1646)	Long-term cardiac follow Up after dose-dense anthracycline based chemotherapy for breast cancer
		M. Heckmann, J. Lehmann, F. Roll, N. Frey, A. Schneeweiss, F. Marme, L. H. Lehmann (Heidelberg, Mannheim)
		Diskussion
	(V1647)	Incidence of cancer therapy-related cardiovascular toxicity according to the International Society of Cardio-Oncology definitions in patients treated with immune checkpoint inhibitor therapy
		R. Mincu, L. Lampe, L. Michel, S. Margraf, J. Pohl, L. Scheipers, T. Rassaf, M. Totzeck (Essen)
		Diskussion